- Home
- KLTOW vs OCCIN Comparison
KLTOW vs OCCIN Comparison
Compare KLTOW & OCCIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KLTOW | OCCIN |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | 3 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | KLTOW | OCCIN |
|---|---|---|
| Price | $0.10 | $24.69 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 9.3K | 3.0K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.01 | $23.51 |
| 52 Week High | $0.95 | $24.87 |
Technical Indicators
Market Signals| Indicator | KLTOW | OCCIN |
|---|---|---|
| Relative Strength Index (RSI) | 52.21 | 53.40 |
| Support Level | $0.07 | $24.28 |
| Resistance Level | $0.11 | $24.81 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 39.73 | 81.25 |
Price Performance
Historical ComparisonAbout KLTOW Klotho Neurosciences Inc. Warrant
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About OCCIN OFS Credit Company Inc.
OFS Credit Co Inc is a non-diversified, closed-end management investment company. Its investment objective is to generate current income, with a secondary objective to generate capital appreciation through investment in collateralized loan obligation (CLO) equity and debt securities. The company invests in floating rate credit instruments and other structured credit investments, including collateralized loan obligation (CLO) debt and subordinated (i.e., residual or equity) securities; traditional corporate credit investments, including leveraged loans and high yield bonds; opportunistic credit investments, including stressed and distressed credit situations and long/short credit investments; and other credit-related instruments.